YMRC
ADAP

Yorktown Management & Research Company’s Adaptimmune Therapeutics ADAP Stock Holding History

Yorktown Management & Research Company’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-32,000
Closed -$261K – 291
2016
Q2 		$261K Buy
+32,000
New +$261K 0.06% 211